Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03920774 · ClinicalTrials.gov registry record
The Natural History of Familial Dysautonomia
A clinical trial of Familial Dysautonomia (Riley-Day Syndrome) and Hereditary Sensory and Autonomic Neuropathies, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 400
- Enrollment target
- 2
- Study locations
NCT03920774: Recruiting study of Familial Dysautonomia (Riley-Day Syndrome) and Hereditary Sensory and Autonomic Neuropathies, sponsored by NYU Langone Health.
NCT03920774 is a study of Familial Dysautonomia (Riley-Day Syndrome) and Hereditary Sensory and Autonomic Neuropathies that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 400 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03920774, a study of Familial Dysautonomia (Riley-Day Syndrome) and Hereditary Sensory and Autonomic Neuropathies, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features of patients with FD overtime by storing their routine clinical test results in a central database. The study will involve collaborators at other specialist clinics around the world who follow/evaluate patients with FD annually. Providing blood for future use is optional.
Primary Outcome
Investigators will create an enrollment database of patients with familial dysautonomia. All patients will have standardized phenotypic evaluations that will combine clinical, physiological and biochemical strategies to characterize complex autonomic phenotypes, both known and still undiscovered.
Conditions Studied
Study Locations (2)
New York
- Dysautonomia Center - School of Medicine -NYU Langone Medical Center - New York
Ramat Gan
- Sheba Medical Center - Safra Children's Hospital - Tel Litwinsky
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2028-12-31 |
What NCT03920774 shows while recruiting
NCT03920774 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Familial Dysautonomia (Riley-Day Syndrome) appearing as the primary indexed condition, and to 0 interventions.
NCT03920774 reports a single indexed study location in New York, Ramat Gan.
Frequently Asked Questions
What is clinical trial NCT03920774 about?
NCT03920774 is a clinical study titled "The Natural History of Familial Dysautonomia". The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study wil...
What is the current status of trial NCT03920774?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2017-02-22. Estimated completion is 2028-12-31.
What conditions does trial NCT03920774 study?
This clinical trial studies the following conditions: Familial Dysautonomia (Riley-Day Syndrome), Hereditary Sensory and Autonomic Neuropathies, Hereditary Sensory and Autonomic Neuropathy 3.
Who is sponsoring clinical trial NCT03920774?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03920774 being conducted?
This trial has 2 study locations across New York, Ramat Gan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI